Lactadherin and procoagulant activities of red blood cells in cyclosporine induced thrombosis

Chinese Medical Journal

Volumn 122, Issue 14, 2009, Pages 1674-1680

  Zheng, Yi Ning ^a   Yu, Hong Juan ^a   Hou, Jin Xiao ^a   Lu, Cheng Fang ^a   Zhou, Jin ^a,a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cyclosporine; Lactadherin; Procoagulant activity; Red blood cell

Indexed keywords

BLOOD CLOTTING FACTOR 10A; CYCLOSPORIN A; FLUORESCEIN ISOTHIOCYANATE; INTRINSIC FACTOR; LACTADHERIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PROCOAGULANT; THROMBOPLASTIN;

ADULT; ARTICLE; BLOOD CLOTTING TIME; BLOOD CULTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYMATIC ASSAY; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN EXPRESSION; THROMBOGENICITY; THROMBOSIS;

ADULT; ANIMALS; ANNEXIN A5; CATTLE; CELL MEMBRANE; CELLS, CULTURED; CYCLOSPORINE; ERYTHROCYTES; FLOW CYTOMETRY; HUMANS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; MILK PROTEINS; PHOSPHATIDYLSERINES; THROMBOSIS;

EID: 70349546217     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.14.013     Document Type: Article

References (26)

1. Kahan BD. Cyclosporine. N Engl J Med 1989; 321: 1725-1738.
2. Ito C, Ribeiro RC, Behm FG, Raimondi SC, Pui CH, Campana D. Cyclosporine A induces apoptosis in childhood acute lymphoblastic leukemia cells. Blood 1998; 91: 1001-1007.
3. Hochstetler LA, Flanigan MJ, Lager DJ. Transplant associated thrombotic microangiopathy: the role of IgG administration as initial therapy. Am J Kidney Dis 1994; 23: 444-450.
4. Vanrenterghem Y, Roels L, Lerut T, Gruwez J, Michielsen P, Gresele P, et al. Thromboembolic complications and haemostatic changes in cyclosporine treated cadaveric kidney allograft recipients. Lancet 1985; 1: 999-1002.
5. Walter DH, Haendeler J, Galle J, Zeiher AM, Dimmeler S. Cyclosporine A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria. Circulation 1998; 98: 1153-1157.
6. Bossaler C, Forstermann U, Hertel R, Olbricht C, Reschke V, Fleck E. Cyclosporine A inhibits endothelium dependent vasodilatation and vascular prostacyclin production. Eur J Pharmacol 1989; 165: 165-169.
7. Irish A. Renal allograft thrombosis: can thrombophilia explain the inexplicable? Nephrol Dial Transplant 1999; 14: 2297-2303.
8. Tomasiak M, Rusak T, Gacko M, Stelmach H. Cyclosporine enhances platelet procoagulant activity. Nephrol Dial Transplant 2007; 22: 1750-1756.
9. Andrews DA, Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol 1999; 6: 76-82.
10. Ademoglu E, Tamer S, Albeniz I, Gokkusu C, Tanrikulu S. Cyclosporine A associated changes in red blood cell membrane composition, deformability, blood and plasma viscosity in rats. Acta Haematol 2004; 112: 184-188.
11. Setty BN, Rao AK, Stuart MJ. Thrombophilia in sickle cell disease: the red cell connection. Blood 2001; 98: 3228-3233.
12. Bonomini M, Sirolli V, Merciaro G, Antidormi T, Di Liberato L, Brummer U, et al. Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine. Nephrol Dial Transplant 2005; 20: 361-366.
13. Atichartakarn V, Angchaisuksiri P, Aryurachai K, Onpun S, Chuncharunee S, Thakkinstian A, et al. Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/ beta thalassaemic patients. Br J Haematol 2002; 118: 893-898.
14. Cappellini MD. Coagulation in the pathophysiology of hemolytic anemias. Hematology Am Soc Hematol Educ Program 2007; 2007: 74-78.
15. Wahid ST, Marshall SM, Thomas TH. Increased platelet and erythrocyte external cell membrane phosphatidylserine in type 1 diabetes and microalbuminuria. Diabetes Care 2001; 24: 2001-2003.
16. Lu CF, Yu HJ, Hou JX, Zhou J. Increased procoagulant activity of red blood cells in the presence of cisplatin. Chin Med J 2008; 121: 1775-1780.
17. Shi J, Shi Y, Waehrens LN, Rasmussen JT, Heegaard CW, Gilbert GE. Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death. Cytometry A 2006; 69: 1193-1201.
18. Shi J, Gilbert GE. Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid binding sites. Blood 2003; 101: 2628-2636.
19. Niemoeller OM, Akel A, Lang PA, Attanasio P, Kempe DS, Hermle T, et al. Induction of eryptosis by cyclosporine. Naunyn Schmiedebergs Arch Pharmacol 2006; 374: 41-49.
20. Hvarregaard J, Andersen MH, Berglund L, Rasmussen JT, Petersen TE. Characterization of glycoprotein PAS-6/7 from membranes of bovine milk fat globules. Eur J Biochem 1996; 240: 628-636.
21. Gilbert GE, Arena AA. Activation of the factor VIIIa factor IXa enzyme complex of blood coagulation by membranes containing phosphatidyl L serine. J Biol Chem 1996; 271: 11120-11125.
22. Govers-Riemslag JW, Janssen MP, Zwaal RF, Rosing J. Prothrombin activation on dioleoylphosphatidylcholine membranes. Eur J Biochem 1994; 220: 131-138.
23. Akhlaghi F, Trull AK. Distribution of cyclosporine in organ transplant recipients. Clin Pharmacokinet 2002; 41: 615-637.
24. Lang KS, Lang PA, Bauer C, Duranton C, Wieder T, Huber SM, et al. Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 2005; 15: 195-202.
25. Albanyan AM, Murphy MF, Rasmussen JT, Heegaard CW, Harrison P. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V. Transfusion 2009; 49: 99-107.
26. Armstrong VW, Oellrich M. New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus and azathioprine. Clin Biochem 2001; 34: 9-16.